Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Methyl bromoacetate → 4-Phenyl-4-((1-(3,5-bis(trifluoromethyl)phenyl)-2-methoxycarbonylmethoxy ethoxy)methyl)piperidine Hydrochloride
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Methyl bromoacetate | HCID 60984 | — |
| 반응물 | 4-Phenyl-4-((1-(3,5-bis(trifluoromethyl)phenyl)-2-hydroxyethoxy) methyl)piperidine Hydrochloride | HCID 19084700 | — |
| 생성물 | 4-Phenyl-4-((1-(3,5-bis(trifluoromethyl)phenyl)-2-methoxycarbonylmethoxy ethoxy)methyl)piperidine Hydrochloride | HCID 19084710 | — |
반응 단계
Prepared from the compound of Example 1 (d) by the method of Example 2, using methyl bromoacetate in place of methyl iodide. 1H NMR (360 MHz, d6 -DMSO) δ 2.00-2.12 (2H, m), 2.24-2.35 (2H, m), 2.62-2.77 (2H, m), 3.17 (2H, br m), 3.29 (1H, d, J=6.0 Hz), 3.62 (3H, s+m), 4.01 (2H, s), 4.08 (1 H, t, J=6.0 Hz), 7.24-7.41 (5H, m), 7.68 (2H, s), 7.97 (1 H, s). MS (EI+) 520 (M+H+).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05760018 |
| 출처 데이터셋 | uspto-grants-1998_06 |
| ORD ID | ord-d59441a1ba1c451c8edfc00544f2ef1d |
| 출처 메모 | uspto-grants-1998_06 |